10,000-Patient trial tests smartphone app to manage diabetes with ancient and modern medicine

NCT ID NCT07265037

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test a new digital platform that combines traditional Chinese medicine with Western medicine to help people with type 2 diabetes manage their condition remotely. The platform includes a smartphone app, connected glucose monitors, and support from both TCM and Western medicine experts. Researchers aim to see if this approach improves blood sugar control and reduces complications over six months in 10,000 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Integrated TCM-Western Medicine Intelligent Diabetes Management Platform (digital platform with connected devices, app, and cloud services)
What this could lead to
If successful, this could offer a scalable, low-cost way to manage diabetes long-distance, potentially reducing complications and improving quality of life for millions.
What could go wrong
This is a large but early-stage feasibility study without a control group, so results may not prove the platform is better than standard care. Success depends on patient engagement and technology reliability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC DISEASE MANAGEMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Shanxi Bethune Hospital

    RECRUITING

    Taiyuan, Shanxi, 030000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.